13F

Stock

Xilio Therapeutics, Inc.

XLO · held by 37 managers

Reported value

$25.3M

Holders

37

+0 new · −0 exited

Holders’ est. mark

−$170.1K

Price effect on 2 books still in the name

Largest holder

$5.83M

GILEAD SCIENCES, INC.

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GILEAD SCIENCES, INC.9.11M$5.83M—Held
Bain Capital Life Sciences Investors, LLC7.37M$4.72M—Held
Frazier Life Sciences Management, L.P.5.92M$3.79M—Held
Point72 Asset Management, L.P.4M$2.56M—Held
Sio Capital Management, LLC2.13M$1.37M—Held
STEMPOINT CAPITAL LP2.03M$1.3M—Held
Merck & Co., Inc.1.48M$949.9K—Held
Vanguard1.26M$803.6K—Held
Empery Asset Management, LP1.18M$757.4K—Held
Ghisallo Capital Management LLC1.11M$712.7K—Held
MORGAN STANLEY839.9K$537.7K−$170.1KCut−$272.9K
AJU IB Investment Co., Ltd.667.7K$427.5K—Held
Fidelity511.8K$327.7K—Held
Citadel436.2K$279.3K—Held
Renaissance Technologies344.4K$220.5K—Held
GEODE CAPITAL MANAGEMENT, LLC329K$210.6K—Held
State Street186.4K$119.3K—Held
Velan Capital Investment Management LP170K$108.8K—Held
Stonepine Capital Management, LLC126.3K$80.8K—Held
NORTHERN TRUST CORP66.6K$42.6K—Held
TWO SIGMA INVESTMENTS, LP62K$39.7K—Held
BRIDGEWAY CAPITAL MANAGEMENT, LLC56.1K$35.9K—Held
JANE STREET GROUP, LLC42.1K$26.9K—Held
Mariner, LLC25K$16K—Held
LPL Financial LLC21K$13.4K—Held
RAYMOND JAMES FINANCIAL INC18.8K$12K—Held
XTX Topco Ltd17.3K$11.1K—Held
Dunhill Financial, LLC10.3K$6.58K—Held
Pinnacle Financial Group, LLC / IL10K$6.4K—Held
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV10K$6.4K—Held
BlackRock, Inc.2.04K$1.3K—Held
Key Financial Inc830$531—Held
Private Wealth Management Group, LLC310$199—Held
BANK OF AMERICA CORP /DE/261$167−$50Cut−$40
UBS Group AG203$130—Held
GSA CAPITAL PARTNERS LLP148K$95—Held
HRT FINANCIAL LP31.9K$20—Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.